TF and peripheral arterial disease: The dual antiplatelet therapy with ASA and clopidogrel resulted in a decrease in the thrombin peak in the presence of platelets (PRP) compared to ASA monotherapy in the same patients with PAD when TF was used as a trigger (Figure 3).